Medical Innovation at a Crossroads: Choosing the Path Ahead
January 12, 2011

This event will examine how the U.S. can best foster investment in medical innovation as a way to reclaim our global competiveness, position the nation as a true global leader, and bend the cost curve to reduce health care costs and thus the deficit – all while finding treatments and cures for the most devastating of diseases. Rob Atkinson will be participating in this event.
Editors’ Recommendations
January 7, 2015
IPRs and Access to Medicines: New Evidence
January 6, 2015
Who’s a Health IT “Luddite?”
November 18, 2014